The classification of drugs have been around since 1964 after Sir James Black discovered how they can assist people with ...

In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Congestive heart failure is a disease state distinguished by the regular presence of both renal and hepatic abnormalities in drug handling. One such abnormality involves flaws in the process of ...

In a pivotal decision Friday, the Federal Circuit revived a key patent for Novartis' blockbuster heart failure drug Entresto, ...

New analysis from GlobalData spans the growth of the heart failure market across seven major markets including the US, Europe ...

Cytokinetics' hopes of resurrecting cardiac myosin activator omecamtiv mecarbil have suffered another setback, after the drug failed to show a benefit in a phase 3 heart failure study. In the ...

A new clinic to treat heart failure patients closer to home has opened. The nurse-led centre opened at Cromer Hospital, ...

On Friday he announced that he and MyoKardia’s executive team have raised $300 million for a new heart disease company, ...

Aurelio Rojas Sanchez, a cardiologist based in Malaga, Spain, has warned that ibuprofen and other everyday medications can ...

IPS HEART has been awarded Orphan Drug Designation (ODD) by the FDA for GIVI-MPCs based on its unique ability to create new ...

The new approach is designed to create a connection between the left and right atrial chambers of the heart in a single ...